Bank of Montreal
PCRX icon

Bank of Montreal’s Pacira BioSciences PCRX Stock Holding History

Bank of Montreal’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,435
Closed -$225K – 3744
2025
Q2 		$225K Sell
9,435
-17,613
-65% -$444K ﹤0.01% 2742
2025
Q1 		$672K Sell
27,048
-7,510
-22% -$180K ﹤0.01% 2012
2024
Q4 		$651K Sell
34,558
-5,027
-13% -$88.3K ﹤0.01% 2086
2024
Q3 		$576K Buy
39,585
+16,760
+73% +$287K ﹤0.01% 2320
2024
Q2 		$656K Buy
22,825
+17,882
+362% +$509K ﹤0.01% 2243
2024
Q1 		$146K Sell
4,943
-2,075
-30% -$63.7K ﹤0.01% 3175
2023
Q4 		$240K Buy
7,018
+835
+14% +$24.4K ﹤0.01% 3008
2023
Q3 		$214K Buy
6,183
+648
+12% +$23.4K ﹤0.01% 3028
2023
Q2 		$229K Sell
5,535
-1,190
-18% -$49.2K ﹤0.01% 3141
2023
Q1 		$275K Buy
6,725
+2,603
+63% +$104K ﹤0.01% 2834
2022
Q4 		$181K Sell
4,122
-842
-17% -$41K ﹤0.01% 3193
2022
Q3 		$270 Buy
4,964
+271
+6% +$15.1K ﹤0.01% 3006
2022
Q2 		$272 Sell
4,693
-7,489
-61% -$491K ﹤0.01% 3072
2022
Q1 		$929K Buy
12,182
+136
+1% +$9.07K ﹤0.01% 2399
2021
Q4 		$753K Sell
12,046
-3,165
-21% -$175K ﹤0.01% 2118
2021
Q3 		$863K Sell
15,211
-260
-2% -$15K ﹤0.01% 2578
2021
Q2 		$964K Buy
15,471
+2,317
+18% +$147K ﹤0.01% 2507
2021
Q1 		$902K Buy
13,154
+1,396
+12% +$99.7K ﹤0.01% 2271
2020
Q4 		$841K Buy
11,758
+7,776
+195% +$455K ﹤0.01% 2356
2020
Q3 		$235K Sell
3,982
-1,344
-25% -$78.1K ﹤0.01% 2665
2020
Q2 		$307K Buy
5,326
+3,597
+208% +$150K ﹤0.01% 2507
2020
Q1 		$56K Sell
1,729
-4,702
-73% -$195K ﹤0.01% 2848
2019
Q4 		$292K Buy
6,431
+1,599
+33% +$67.9K ﹤0.01% 2955
2019
Q3 		$183K Buy
4,832
+1,122
+30% +$44.8K ﹤0.01% 2966
2019
Q2 		$161K Sell
3,710
-39,040
-91% -$1.66M ﹤0.01% 3049
2019
Q1 		$1.63M Buy
42,750
+3,880
+10% +$151K ﹤0.01% 1792
2018
Q4 		$1.67M Sell
38,870
-422
-1% -$19.7K ﹤0.01% 1626
2018
Q3 		$1.93M Buy
39,292
+1,064
+3% +$46K ﹤0.01% 1688
2018
Q2 		$1.23M Sell
38,228
-10,045
-21% -$347K ﹤0.01% 1900
2018
Q1 		$1.5M Buy
48,273
+19,526
+68% +$695K ﹤0.01% 1709
2017
Q4 		$1.31M Sell
28,747
-8,433
-23% -$334K ﹤0.01% 1823
2017
Q3 		$1.4M Buy
37,180
+3,509
+10% +$141K ﹤0.01% 1806
2017
Q2 		$1.61M Sell
33,671
-7,053
-17% -$327K ﹤0.01% 1745
2017
Q1 		$1.86M Sell
40,724
-42,432
-51% -$1.83M ﹤0.01% 1571
2016
Q4 		$2.65M Sell
83,156
-108,390
-57% -$3.62M ﹤0.01% 1389
2016
Q3 		$6.55M Sell
191,546
-182
-0.1% -$7.13K 0.01% 985
2016
Q2 		$6.47M Sell
191,728
-34,115
-15% -$1.68M 0.01% 992
2016
Q1 		$12M Buy
225,843
+19,236
+9% +$1.13M 0.01% 670
2015
Q4 		$15.9M Sell
206,607
-21,059
-9% -$1.19M 0.02% 569
2015
Q3 		$9.36M Buy
227,666
+65,033
+40% +$3.98M 0.01% 733
2015
Q2 		$11.5M Buy
162,633
+11,410
+8% +$899K 0.01% 738
2015
Q1 		$13.4M Sell
151,223
-38,867
-20% -$3.94M 0.02% 676
2014
Q4 		$16.9M Buy
190,090
+8,976
+5% +$849K 0.02% 550
2014
Q3 		$17.6M Sell
181,114
-22,639
-11% -$2.2M 0.02% 556
2014
Q2 		$18.7M Buy
203,753
+6,267
+3% +$477K 0.02% 518
2014
Q1 		$13.8M Sell
197,486
-51,043
-21% -$3.47M 0.02% 549
2013
Q4 		$14.3M Sell
248,529
-56,361
-18% -$2.96M 0.02% 476
2013
Q3 		$14.7M Sell
304,890
-7,118
-2% -$259K 0.02% 412
2013
Q2 		$9.05M Buy
+312,008
New +$9.03M 0.02% 524

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of Montreal's PCRX Position: Q3 2025 in Review

Bank of Montreal sold out of Pacira BioSciences (PCRX) in Q3 2025, closing a stake of 9,435 shares — an estimated $225K sold.

Bank of Montreal first reported a position in PCRX in Q2 2013 and held it in 49 quarters. The position peaked at $18.7M in Q2 2014. 239 funds tracked by Wall St. Rank hold PCRX as of Q3 2025.

  • Bank of Montreal reported no remaining Pacira BioSciences position as of Q3 2025 after selling out during the quarter.
  • Bank of Montreal sold 9,435 Pacira BioSciences shares in Q3 2025, an estimated $225K.
  • Bank of Montreal first reported a position in Pacira BioSciences in Q2 2013 and held it in 49 quarters.
  • Bank of Montreal's Pacira BioSciences position peaked at $18.7M in Q2 2014.
  • 239 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2025.

Based on Bank of Montreal's 13F filing for Q3 2025, filed 13 Nov 2025.